Article Name Medtech

Berlin’s Dopavision announces clinical trial results of ‘targeted photobiomodulation’ for progressive myopia

MyopiaX-1 proof-of-concept clinical trial supports MyopiaX’s safety and tolerability profile ...Read more

28th May, 2024


Terumo Cardiovascular announces US FDA 510(K) clearance for CDI OneView monitoring system

Modular, expandable design displays up to 22 vital patient parameters with real-time convenience...Read more

28th May, 2024


TVM Capital Healthcare closes Saudi Arabia-focused TVM Healthcare Afiyah Fund

Major focus of the fund on supporting medical priorities of Saudi's Vision 2030 ...Read more

28th May, 2024


Lifespin GmbH and Acıbadem forge ‘Metabolomics’ partnership to advance personalised medicine

To develop global market for healthcare solutions that utilise NMR and AI technologies...Read more

28th May, 2024


MedTech CROs: Transforming Ideas into Market-Ready Medical Devices

From Regulatory Guidance to Clinical Trial Management, MedTech CROs Accelerate the Journey of Innovative Medical Devices to Market...Read more

28th May, 2024 | By Ankit Kankar | ankit.kankar@mmactiv.com 


Gerresheimer expands capacities for Medical Systems in US

More than 400 new jobs for skilled workers from the region...Read more

27th May, 2024


New study supports efficacy of robotic-assisted partial nephrectomy in renal mass surgery

Study supports the value and benefits of the robotic approach to partial nephrectomy in India...Read more

25th May, 2024


Dr. Reddy's Labs announces launch of Nerivio in Spain for migraine treatment

Nerivio is planned to be launched in the United Kingdom next June...Read more

25th May, 2024


Korean medtech startup HoneyNaps secures $11.6 M Series B investment

Propelling its entry into the American medical market...Read more

24th May, 2024


WHO approves largest number of regulatory agencies for medical products

Decision is based on the recommendation by the WHO technical advisory group...Read more

22nd May, 2024


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer